Search for: "Johnson v. Bristol-Myers Squibb Company" Results 1 - 20 of 30
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Jan 2024, 4:35 pm
https://responsibletechnology.org/ge-soil-microbes-new-target-for-agrichemical- companies/ Rhinos cont'd. [read post]
8 Jun 2023, 7:43 am by Ashwin Varma
Examples of the latter include the Bristol-Myers-Squibb – Celgene merger in 2018, and the Merck-Wyeth merger of 2009. [read post]
8 Jun 2023, 7:43 am by Ashwin Varma
Examples of the latter include the Bristol-Myers-Squibb – Celgene merger in 2018, and the Merck-Wyeth merger of 2009. [read post]
27 Jan 2017, 12:52 pm by John Elwood
The court also granted last Thursday in the much less colorful two-time relist Bristol-Myers Squibb Company v. [read post]
12 Jan 2017, 7:01 am by John Elwood
(relisted after the December 9, 2016, and January 6, 2017, conferences)   Johnson v. [read post]
11 Jan 2017, 7:19 am by Kate Howard
The Bear Stearns Companies LLC 16-372 Disclosure: Goldstein & Russell, P.C., whose attorneys contribute to this blog in various capacities, is among the counsel to the petitioner in this case. [read post]
26 Jun 2015, 11:30 am
  For whatever reason, California courts have seemed open to hosting plaintiffs from everywhere, a point well exemplified by our Hotel California post discussing the now-vacated Bristol-Myers Squibb Co. v. [read post]
26 Feb 2015, 5:00 am
  In Henderson, the plaintiff failed to prove negligence but claimed that “‘even if the Drug Company was not negligent . [read post]
18 Jul 2014, 11:55 am
Wyeth, Inc., ___ N.W.2d ___, 2014 WL 3377071 (Iowa July 11, 2014), but Huck isn’t even the last  case on our scorecard any longer – that honor currently belongs to Johnson v. [read post]
18 Jun 2012, 1:38 pm
In the back of the Court’s mind, of course, was January’s $99 million settlement by Novartis for overtime claims by its pharmaceutical sales representatives following the Second Circuit’s 2010 decision in In re Novartis Wage & Hour Litig., and similar pending cases against Johnson & Johnson, Merck Co. and Bristol-Myers Squibb. [read post]